BSE Prices delayed by 5 minutes ! Prices as on   Apr 26, 2024 - 4:00PM   ABB India 6409.05 [ -0.41% ]ACC 2524.4 [ -2.14% ]Ambuja Cements 632.05 [ -0.99% ]Asian Paints Ltd. 2844.6 [ -0.59% ]Axis Bank Ltd. 1130.05 [ 0.24% ]Bajaj Auto 8948.05 [ 2.40% ]Bank of Baroda 268.15 [ -0.20% ]Bharti Airtel 1325.5 [ -0.78% ]Bharat Heavy Ele 278.8 [ 2.65% ]Bharat Petroleum 609.4 [ 0.94% ]Britannia Ind. 4797.55 [ -1.06% ]Cipla 1406.25 [ 0.06% ]Coal India 455.55 [ 0.62% ]Colgate Palm. 2864.6 [ 2.33% ]Dabur India 509 [ 0.44% ]DLF Ltd. 907.7 [ 1.47% ]Dr. Reddy's Labs 6263.7 [ 0.75% ]GAIL (India) 208 [ -0.02% ]Grasim Inds. 2338 [ -1.33% ]HCL Technologies 1476.8 [ -1.79% ]HDFC 2729.95 [ -0.62% ]HDFC Bank 1509.75 [ -0.06% ]Hero MotoCorp 4487.75 [ -0.10% ]Hindustan Unilever L 2221.5 [ -0.43% ]Hindalco Indus. 649.75 [ 0.50% ]ICICI Bank 1107.15 [ -0.53% ]IDFC L 127.25 [ 2.33% ]Indian Hotels Co 568.35 [ -1.54% ]IndusInd Bank 1445.85 [ -3.36% ]Infosys L 1430.15 [ -0.57% ]ITC Ltd. 439.95 [ 0.56% ]Jindal St & Pwr 931.95 [ -1.15% ]Kotak Mahindra Bank 1608.4 [ -2.11% ]L&T 3602.3 [ -1.32% ]Lupin Ltd. 1615.85 [ 1.31% ]Mahi. & Mahi 2055 [ -1.94% ]Maruti Suzuki India 12687.05 [ -1.70% ]MTNL 37.5 [ 0.13% ]Nestle India 2483.8 [ -3.08% ]NIIT Ltd. 108.15 [ 0.46% ]NMDC Ltd. 257.8 [ 2.18% ]NTPC 355.75 [ -0.71% ]ONGC 282.85 [ 0.28% ]Punj. NationlBak 136.45 [ 0.44% ]Power Grid Corpo 292.6 [ -0.17% ]Reliance Inds. 2903 [ -0.53% ]SBI 801.4 [ -1.38% ]Vedanta 396.65 [ 4.16% ]Shipping Corpn. 232.65 [ -0.04% ]Sun Pharma. 1504.25 [ -1.07% ]Tata Chemicals 1122.45 [ 0.92% ]Tata Consumer Produc 1102.9 [ -0.28% ]Tata Motors Ltd. 999.35 [ -0.14% ]Tata Steel 165.85 [ -1.04% ]Tata Power Co. 436.75 [ 1.22% ]Tata Consultancy 3825 [ -0.70% ]Tech Mahindra 1277.45 [ 7.34% ]UltraTech Cement 9735.35 [ 0.53% ]United Spirits 1197.9 [ 0.36% ]Wipro 464.65 [ 0.79% ]Zee Entertainment En 145.95 [ 2.24% ]

MARKETS

News Details

( As on 02/03/2021 09:30)

Cipla partners with Alvotech to market biosimilars in Australia and New Zealand

Cipla announced that its subsidiary, Cipla Gulf FZ LCC (Cipla Gulf) is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.

As part of this strategic alliance, Cipla Gulf will be responsible for commercialization of patented biosimilars of the biologic medicine brands, Aflibercept (Eylea), Ustekimumab (Stelara), Denosumab (Prolia, Xgeva) and Golimumab (Simponi). These are leading products covering therapeutic categories across immunology, osteoporosis, oncology as well as ophthalmology (eg.

Aflibercept is indicated for nAMD and other serious eye diseases).

The products are developed and manufactured by Alvotech and will be distributed by Cipla Gulf through Australia and New Zealand distribution networks. These innovative products recorded US$700 million in aggregate 2020 sales in Australia.

Cipla Gulf had previously entered into a similar agreement with Alvotech in July 2019 for the commercialization of AVT02, an adalimumab biosimilar, in select emerging markets.